1. Morris NA, Matiello M, Lyons JL, Samuels MA. Neurologic complications in infective endocarditis: identification, management, and impact on cardiac surgery. Neurohospitalist. 2014; 4(4): 213-22. [
View at Publisher] [
DOI:10.1177/1941874414537077] [
PubMed] [
Google Scholar]
2. Dhotre S, Jahagirdar V, Suryawanshi N, Davane M, Patil R, Nagoba B. Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis. Indian Heart J. 2018; 70(2): 225-32. [
View at Publisher] [
DOI:10.1016/j.ihj.2017.06.019] [
PubMed] [
Google Scholar]
3. Lin YT, Hsieh KS, Chen YS, Huang IF, Cheng MF. Infective endocarditis in children without underlying heart disease. J Microbiol Immunol Infect. 2013 Apr 1;46(2):121-8. [
View at Publisher] [
DOI:10.1016/j.jmii.2012.05.001] [
PubMed] [
Google Scholar]
4. Terpening MS, Buggy BP, Kauffman CA. Infective endocarditis: Clinical features in young and elderly patients. Am J Med. 1987 Oct 1;83(4):626-34. [
View at Publisher] [
DOI:10.1016/0002-9343(87)90890-4] [
PubMed] [
Google Scholar]
5. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015; 132(15): 1435-86. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
6. Grüneberg RN, Antunes F, Chambers HF, Garau J, Graninger W, Menichetti F, et al. The role of glycopeptide antibiotics in the treatment of infective endocarditis. Int J Antimicrob Agents. 1999; 12(3): 191-8. [
View at Publisher] [
DOI:10.1016/S0924-8579(99)00006-0] [
PubMed] [
Google Scholar]
7. Cabell C, Abrutyn E, Karchmer A. Bacterial Endocarditis: The Disease, Treatment, and Prevention. Circulation. 2003; 129(20): e185-7. [
View at Publisher] [
DOI:10.1161/01.CIR.0000071082.36561.F1] [
Google Scholar]
8. Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2015 Nov 1;33(9):625.e1-625.e23. [
View at Publisher] [
DOI:10.1016/j.eimc.2015.03.015] [
PubMed] [
Google Scholar]
9. Johnson MD, Johnson CD. Neurologic presentations of infective endocarditis. Neurol Clin. 2010; 28(1): 311-21. [
DOI:10.1016/j.ncl.2009.09.001] [
PubMed] [
Google Scholar]
10. Rubinos C, Ruland S. Neurologic Complications in the Intensive Care Unit. Curr Neurol Neurosci Rep. 2016; 16(6). [
DOI] [
PubMed] [
Google Scholar]
11. Deprèle C, Berthelot P, Lemetayer F, Comtet C, Fresard A, Cazorla C, et al. Risk factors for systemic emboli in infective endocarditis. Clin Microbiol Infect. 2004; 10(1): 46-53. [
View at Publisher] [
DOI:10.1111/j.1469-0691.2004.00735.x] [
PubMed] [
Google Scholar]
12. Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, et al. Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis. 2014; 14: 230. [
View at Publisher] [
DOI:10.1186/1471-2334-14-230] [
PubMed] [
Google Scholar]
13. Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017; 48(2): e44-e71 [
View at Publisher] [
DOI:10.1161/STR.0000000000000116] [
PubMed] [
Google Scholar]
14. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008; 39(9): 2644-91. [
View at Publisher] [
DOI:10.1161/STROKEAHA.108.189696] [
PubMed] [
Google Scholar]
15. Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016; 47(2): 581-641. [
View at Publisher] [
DOI:10.1161/STR.0000000000000086] [
PubMed] [
Google Scholar]
16. van der Zijden T, Mondelaers A, Yperzeele L, Voormolen M, Parizel PM. Current concepts in imaging and endovascular treatment of acute ischemic stroke: implications for the clinician [Internet]. Vol. 10, Insights into Imaging. Springer Verlag; 2019 [cited 2021 Apr 12]. p. 64. Available from: https://insightsimaging.springeropen.com/articles/10.1186/s13244-019-0744-4 [
View at Publisher] [
DOI:10.1186/s13244-019-0744-4] [
PubMed] [
Google Scholar]
17. Winder AJ, Siemonsen S, Flottmann F, Thomalla G, Fiehler J, Forkert ND. Technical considerations of multi-parametric tissue outcome prediction methods in acute ischemic stroke patients. Sci Rep [Internet]. 2019 Dec 1 [cited 2021 Apr 12];9(1):1-12. Available from: www.nature.com/scientificreports [
View at Publisher] [
DOI:10.1038/s41598-019-49460-y] [
PubMed] [
Google Scholar]